Development of effective tumor immunotherapy using a novel dendritic cell–targeting Toll-like receptor ligand

Although dendritic cell (DC)-based immunotherapy shows little toxicity, improvements should be necessary to obtain satisfactory clinical outcome. Using interferon-gamma injection along with DCs, we previously obtained significant clinical responses against small or early stage malignant tumors in do...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Autores principales: De Silva, Nadeeka H., Akazawa, Takashi, Wijewardana, Viskam, Inoue, Norimitsu, Oyamada, Maremichi, Ohta, Atsuko, Tachibana, Yuki, Wijesekera, Daluthgamage Patsy H., Kuwamura, Mitsuru, Nishizawa, Yasuko, Itoh, Kazuyuki, Izawa, Takeshi, Hatoya, Shingo, Hasegawa, Tetsuya, Yamate, Jyoji, Inaba, Toshio, Sugiura, Kikuya
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5708771/
https://ncbi.nlm.nih.gov/pubmed/29190690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0188738
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares